Moderna plunges 18% after cancer-vaccine data leak with Merck
FROM THE WIRE · FINANCE.YAHOO.COM
Moderna shares tumbled as reported results for its cancer vaccine with Merck circulated ahead of a planned conference presentation. Continue Reading
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bearishA nearly 18% drop in a biotech stock after early circulation of cancer vaccine results.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Moderna shares tumbled after reported results for its cancer vaccine with Merck circulated.
- 02The results circulated ahead of a planned conference presentation.
- 03The news also involves partner Merck.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Moderna, Inc.202.63 USDMarket closedtoday -17.57%Negative Merck & Co., Inc.147.24 USDMarket closedtoday -1.76%Neutral
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets